Fridays offers a broad support package, but its pricing and outcome language need careful reading. The lowest visible quote belongs to an annual promotion, and its success-rate figure is an operational measure.
- Published pricing
- From $99 / month advertised
- Price conditions
- Semaglutide annual-plan promotion; verify commitment and code
- Checked
- October 10, 2026
What stands out
- Clinical visits and coaching described
- Annual offers identified separately
- Brand-name access also listed
What to weigh
- The prominently advertised success rate concerns fulfillment, not weight loss.
- No hands-on treatment or support testing
The current visible offer and its conditions
The rendered pricing page displayed semaglutide from $99 per month with an annual plan and code FOREVER12. Tirzepatide was advertised from $198 per month with an annual plan and code FOREVER500. We inspected the visible page because extracted text also contained other offer variants. The annual condition belongs next to the price.[source]
A monthly equivalent is not evidence that the plan can be purchased one month at a time at that rate. Confirm the full commitment, payment schedule and refund treatment if prescribing changes. The promotion’s “forever” language should be read with its current terms; it is not our guarantee of an unchangeable price.
What the bundled service advertises
The signature plans describe provider visits, nutrition and mental-health coaching, and dietitian and journey support, with membership included. Those can be relevant differences for someone who wants structured follow-up. We have not measured availability, appointment frequency or response time, so a long feature list should become a set of questions about actual access.[source]
The brand-name pathways have different pricing. For example, the Wegovy listings show a first-month membership figure that excludes medication, with subsequent membership terms in a footnote. Do not carry a “medication included” interpretation from a signature compounded plan onto every product card.
A success rate can describe the order, not the patient
Fridays displays a 96.8% success figure. Its footnote explains that the measure concerns recent internal fulfillment and delivery performance for paid orders, not clinical outcomes. That makes it unsuitable as an estimate of a customer’s likelihood of losing weight.[source]
The page also identifies certain testimonials as paid. Testimonials describe selected experiences; they are not a controlled comparison with CoreAge Rx or another provider. We do not turn a marketing ranking or a customer story into evidence of fewer side effects or superior effectiveness.
How to compare the service responsibly
Start with the medicine and route a clinician considers appropriate, then compare the support and total commitment. Compounded medicines are not FDA-approved, and the medical basis for prescribing remains separate from the annual promotion. Ask about the dispensing pharmacy, instructions and access to help after delivery.[source]
Fridays belongs in a comparison for its published service bundle and clearly identifiable promotional conditions. A reader prioritizing a short commitment should examine a true month-to-month quote before deciding that the lowest annual equivalent is the affordable choice.
Sources & further reading
Provider pages establish what a brand markets. Clinical and regulatory sources establish the limits of the evidence. Each source has its own last-checked date below.
- Fridays: current pricing, annual offers and disclosuresRendered page checked October 10, 2026. Promotional figures differ from some extracted page text; review uses the visible annual-plan offers. · Checked October 10, 2026
- FDA: concerns with unapproved GLP-1 drugsCompounded-product risks, salt forms, dosing errors and online red flags · Checked October 10, 2026